SCHEMBL4089570

SCHEMBL4089570

CCOC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)nn1C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
POLB P06746 3/20 0.46
MAPT P10636 6/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
HSP90AA1 P07900 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25435732 0.85 ALDH1A1 (0.50) SMN1; SMN2TDP1POLBMAPTKDM4E
SCHEMBL4685138 0.84 FAAH (0.54) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL25433844 0.84 POLB (0.64) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL718675 0.83 SMN1; SMN2 (0.57) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL882358 0.82 SMN1; SMN2 (0.47) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL5025713 0.81 POLB (0.55) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL4681188 0.81 POLB (0.55) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL2423857 0.78 MAPT (0.48) SMN1; SMN2TDP1POLBMAPTKDM4E
SCHEMBL4682094 0.78 SMN1; SMN2 (0.79) SMN1; SMN2TDP1POLBMAPTMEN1
SCHEMBL4095588 0.78 SMN1; SMN2 (0.51) SMN1; SMN2TDP1POLBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta NIPPON CHEMIPHAR CO., LTD. (JP) 2009-09-24 US disclosed
EP-1854784-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2007-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta PPARG, PPARA, PPARD SMN1; SMN2 4112/4885TDP1 4454/4885POLB 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.